News FDA Approves Photrexa for Corneal Crosslinking in Keratoconus by Medscape • 2016/04/19 • 0 Comments The riboflavin ophthalmic solution, once irradiated with ultraviolet A light, treats sight-threatening keratoconus with corneal collagen crosslinking. FDA Approvals Full Story →